Difference between revisions of "Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5 (Q9651)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 7, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 60954-60970, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | PPARgamma agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. (English) | ||
| Property / title: PPARgamma agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 60954-60970 | ||
| Property / Page(s): 60954-60970 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:39, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Basu-Roy U
0 references
2016
0 references
Oncotarget
0 references
7
0 references
PPARgamma agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. (English)
0 references
60954-60970
0 references
